Diagnosis of early gastric cancer

Research output: PatentScientific

Abstract

The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.
Original languageEnglish
Publication Year9 Jul 2002
Publication statusPublished - 9 Jul 2002
MoE publication typeH1 Granted patent

Fields of Science

  • 312 Clinical medicine

Cite this

Ristimäki, A., Harkonen, M., & Sipponen, P. I. (2002). IPC No. C12Q 1/68 (20060101). Diagnosis of early gastric cancer. (Patent No. US patent 6,416,961).
Ristimäki, Ari (Author) ; Harkonen, Matti (Author) ; Sipponen, Pentti Ilmari (Author). / Diagnosis of early gastric cancer. IPC No.: C12Q 1/68 (20060101). Patent No.: US patent 6,416,961. Jul 09, 2002.
@misc{a1d357e093d949a8b62fd63fd62a89e2,
title = "Diagnosis of early gastric cancer",
abstract = "The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.",
keywords = "312 Clinical medicine",
author = "Ari Ristim{\"a}ki and Matti Harkonen and Sipponen, {Pentti Ilmari}",
year = "2002",
month = "7",
day = "9",
language = "English",
type = "Patent",
note = "US patent 6,416,961; C12Q 1/68 (20060101)",

}

Ristimäki, A, Harkonen, M & Sipponen, PI Jul. 09 2002, Diagnosis of early gastric cancer, Patent No. US patent 6,416,961, IPC No. C12Q 1/68 (20060101).

Diagnosis of early gastric cancer. / Ristimäki, Ari; Harkonen, Matti; Sipponen, Pentti Ilmari.

IPC No.: C12Q 1/68 (20060101). Patent No.: US patent 6,416,961. Jul 09, 2002.

Research output: PatentScientific

TY - PAT

T1 - Diagnosis of early gastric cancer

AU - Ristimäki, Ari

AU - Harkonen, Matti

AU - Sipponen, Pentti Ilmari

PY - 2002/7/9

Y1 - 2002/7/9

N2 - The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.

AB - The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.

KW - 312 Clinical medicine

M3 - Patent

M1 - US patent 6,416,961

Y2 - 2002/07/09

ER -

Ristimäki A, Harkonen M, Sipponen PI. Diagnosis of early gastric cancer. C12Q 1/68 (20060101). 2002 Jul 9.